Zydus Lifesciences on Friday said it has received approval from the US health regulator to market a generic medication.   The ...

Zydus Lifesciences receives USFDA approval to market a generic medication for multiple sclerosis, a generic version of ...

Zydus Lifesciences on Friday said it has received approval from the US health regulator to market a generic medication to ...

Zydus Lifesciences said that it has has received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL, single-dose ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...